default author photo

Guido Ferrari

Duke University - Department of Surgery

Durham, NC 27710

United States

SCHOLARLY PAPERS

3

DOWNLOADS

195

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Hybrid Versus Vaccine Immunity of mRNA-1273 Among People Living with HIV in East and Southern Africa: The Multicentre, Open-Label COVPN 3008 (Ubuntu) Clinical Trial

Number of pages: 32 Posted: 11 Jul 2024
Centre for the AIDS Programme of Research in Africa (CAPRISA), University of KwaZulu- Natal, University of Washington, Fred Hutchinson Cancer Research Center, Johns Hopkins Bloomberg School of Public Health, Malawi, Fred Hutchinson Cancer Research Center, University of Zimbabwe, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Duke University - Department of Surgery, Fred Hutchinson Cancer Research Center, Chris Hani Baragwanath Academic Hospital, KwaZulu-Natal Research Innovation and Sequencing Platform - KRISP, University of KwaZulu-Natal, University of KwaZulu-Natal - School of Laboratory Medicine and Medical Sciences, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, National Institutes of Health, National Institutes of Health, COVID-19 Prevention Network, University of Zimbabwe - Faculty of Medicine and Health Sciences, Baylor College of Medicine, Botswana Harvard AIDS Institute Partnership (BHP), Centre for Infectious Disease Research in Zambia, Columbia University - ICAP, Wits University - Clinical HIV Research Unit, Aurum Institute, Synexus Helderberg, University of Cape Town Lung Institute, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), TASK, FAMCRU Family Clinical Research Unit, University of Cape Town (UCT), Aurum Institute, University of North Carolina (UNC) at Chapel Hill - UNC-Project Malawi, Center for Family Health Research Zambia (CFHRZ), The Aurum Institute, Aurum Institute, South African Medical Research Council, UNC Global Projects, Soweto Clinical Trials Centre, Blantyre District Council, Center for Family Health Research Zambia (CFHRZ), Wits Health Consortium - Perinatal HIV Research Unit (PHRU), Synergy Biomed Research Institute, MERC Middelburg, Kisumu Clinical Research Site, TASK, TASK, Aurum Institute, Nelson Mandela Academic Clinical Research Unit Clinical Research Site, University of the Witwatersrand - Perinatal HIV Research Unit, Joint Clinical Research Centre, University of KwaZulu-Natal, South African Medical Research Council, Soweto Clinical Trials Centre, UVRI-IAVI HIV Vaccine Program, MeCRU Clinical Research Site, Maseno University, Synexus Stanza Clinical Research Centre Clinical Research Site, University of KwaZulu-Natal, PHOENIX Pharma (Pty) Ltd, Moi University, University of Cape Town (UCT), MERC Kempton, MERC Welkom, MU-JHU Care Ltd - MUJHU Research Collaboration, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, University of Cape Town (UCT) - Desmond Tutu HIV Centre, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, South African Medical Research Council, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Qhakaza Mbokodo Research Clinic and Independent
Downloads 114 (621,896)

Abstract:

Loading...

People living with HIV, SARS-CoV-2, mRNA-1273, hybrid immunity, vaccine immunity, COVID-19

2.

DNA electroporation of HIV Env elicits unique pattern of immune responses compared to other methods of immunogen delivery, including robust CD8+ responses and memory B cell responses with muted serum antibody levels when boosted with recombinant protein

Number of pages: 32 Posted: 01 Oct 2025
Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Alabama at Birmingham, affiliation not provided to SSRN, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, affiliation not provided to SSRN, Duke University - Duke Human Vaccine Institute, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University, Duke University - Departments of Surgery, Immunology, Molecular Genetics and Microbiology, Duke University - Department of Surgery, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, The Scripps Research Institute, National Institutes of Health, affiliation not provided to SSRN, Columbia University, Vanderbilt University - Division of Infectious Diseases, affiliation not provided to SSRN, Wistar Institute, Wistar Institute, Wistar Institute, Wistar Institute, affiliation not provided to SSRN, Government of the United States of America - Vaccine Research Center, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division and University of Pennsylvania - Vaccine Center
Downloads 42 (1,157,785)

Abstract:

Loading...

HIV-1 vaccine, DNA vaccine, Clinical Trial, neutralizing antibodies, B cell response, CD8+ T cell response

3.

Breadth of SARS-CoV-2 Neutralization and Protection Induced by a Nanoparticle Vaccine

Number of pages: 59 Posted: 18 Feb 2022
Duke University - Duke Human Vaccine Institute, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, University of North Carolina (UNC) at Chapel Hill - Department of Epidemiology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Duke University - Department of Surgery, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Duke University - Duke Human Vaccine Institute, Beth Israel Deaconess Medical Center, University of Pennsylvania - Department of Microbiology, University of Pennsylvania - Department of Microbiology, Corporate Research Materials Lab, 3M Company, Infectious Disease Research Institute, Government of the United States of America - Infectious Disease Pathogenesis Section, Comparative Medicine Branch, BIOQUAL, BIOQUAL, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, Government of the United States of America - Vaccine Research Center, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration - Division of Viral Products, University of North Carolina (UNC) at Chapel Hill - Department of Microbiology and Immunology, Duke University - Duke Human Vaccine Institute, Duke University - Duke Human Vaccine Institute and Duke University - Duke Human Vaccine Institute
Downloads 39 (1,196,171)

Abstract:

Loading...